Q2 2016 Holdings
Filed 2016-08-12 | 23 holdings | $39.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| BioCryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $16.2M | 5,721,142 | 40.9% |
| Ascendis Pharma A/S(ASND) | COM | 04351P101 | $9.6M | 721,152 | 24.1% |
| CytomX Therapeutics Inc(CTMX) | COM | 23284F105 | $5.9M | 577,831 | 14.8% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $4.4M | 259,259 | 11.0% |
| BeiGene Ltd(ONC) | COM | 07725L102 | $3.5M | 119,000 | 8.9% |
| AveXis Inc | COM | 05366U100 | $37.8K | 1,035,657 | 0.1% |
| Edge Therapeutics Inc | COM | 279870109 | $19.5K | 1,933,582 | 0.0% |
| DBV Technologies | COM | F2927N109 | $17.4K | 373,617 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $8.0K | 999,633 | 0.0% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $7.3K | 405,901 | 0.0% |
| Alcobra Ltd | COM | M2239P109 | $6.5K | 1,454,402 | 0.0% |
| Axovant Sciences Ltd | COM | G0750W104 | $5.5K | 429,590 | 0.0% |
| Akari Therapeutics Plc | COM | 00972G108 | $5.0K | 369,490 | 0.0% |
| Cynapsus Therapeutics Inc | COM | 23257Y701 | $4.2K | 253,345 | 0.0% |
| Arca biopharma Inc | COM | 00211Y100 | $3.1K | 1,078,932 | 0.0% |
| Global Blood Therapeutics | COM | 37890U108 | $2.8K | 170,312 | 0.0% |
| Stemline Therapeutics Inc | COM | 85858C107 | $2.1K | 315,980 | 0.0% |
| Ocera Therapeutics | COM | 67552A108 | $1.8K | 948,372 | 0.0% |
| Aeglea BioTherapeutics(AGLEUSD) | COM | 00773J103 | $1.5K | 350,133 | 0.0% |
| Lipocine Inc | COM | 53630X104 | $1.3K | 420,000 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $885 | 280,000 | 0.0% |
| Zafgen Inc | COM | 98885E103 | $847 | 141,479 | 0.0% |
| ProNAI Therapeutics Inc | COM | 74346L101 | $260 | 130,798 | 0.0% |